HK1001719A1 - Muscle relaxant pharmaceutical compositions - Google Patents

Muscle relaxant pharmaceutical compositions

Info

Publication number
HK1001719A1
HK1001719A1 HK98100704A HK98100704A HK1001719A1 HK 1001719 A1 HK1001719 A1 HK 1001719A1 HK 98100704 A HK98100704 A HK 98100704A HK 98100704 A HK98100704 A HK 98100704A HK 1001719 A1 HK1001719 A1 HK 1001719A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
muscle relaxant
tryptophan
serine
glycine
Prior art date
Application number
HK98100704A
Other languages
English (en)
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1001719(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of HK1001719A1 publication Critical patent/HK1001719A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK98100704A 1994-10-21 1998-01-27 Muscle relaxant pharmaceutical compositions HK1001719A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (1)

Publication Number Publication Date
HK1001719A1 true HK1001719A1 (en) 1998-07-03

Family

ID=11369756

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98100704A HK1001719A1 (en) 1994-10-21 1998-01-27 Muscle relaxant pharmaceutical compositions

Country Status (9)

Country Link
EP (1) EP0707853B1 (fr)
AT (1) ATE156016T1 (fr)
CA (1) CA2160938C (fr)
DE (2) DE707853T1 (fr)
DK (1) DK0707853T3 (fr)
ES (1) ES2088379T3 (fr)
GR (2) GR960300039T1 (fr)
HK (1) HK1001719A1 (fr)
IT (1) IT1271031B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU779889B2 (en) * 1999-12-22 2005-02-17 Glaxo Group Limited Methods for preparing pharmaceutical formulations
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
US20070178147A1 (en) * 2005-12-08 2007-08-02 Desai Narendra R Liposomal compositions
EP2712611A1 (fr) 2012-09-27 2014-04-02 B. Braun Melsungen AG Compositions aqueuses stabilisées d'agents de blocage neuromusculaire
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626850B1 (fr) * 1992-02-18 2002-05-15 Pharmos Corporation Compositions seches pour la preparation d'emulsions submicroniques
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
EP0707853B1 (fr) 1997-07-30
GR3024761T3 (en) 1997-12-31
DE69500490T2 (de) 1997-12-04
DE69500490D1 (de) 1997-09-04
EP0707853A1 (fr) 1996-04-24
ITMI942166A0 (it) 1994-10-21
ATE156016T1 (de) 1997-08-15
DK0707853T3 (da) 1998-03-02
DE707853T1 (de) 1996-12-12
ITMI942166A1 (it) 1996-04-21
CA2160938C (fr) 2008-07-15
ES2088379T3 (es) 1997-10-16
IT1271031B (it) 1997-05-26
ES2088379T1 (es) 1996-08-16
CA2160938A1 (fr) 1996-04-22
GR960300039T1 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
PT792287E (pt) Analogos peptidicos da proteina basica da mielina humana
HK1039271A1 (en) Method for prevention and/or cosmetic treatment ofskin stripe and use in dermatology.
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
EA199900194A1 (ru) Реминерализующая композиция
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
HU9503539D0 (en) Process for the light stabilization of sunscreen agents derived from dibenzoylmethane, light-stabilized cosmetic sunscreen compositions thus obtained, and uses thereof
DE69614681T2 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
IL116211A0 (en) Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof
DE69604147D1 (de) Flüssige zuzammensetzung zur stabilisierung von aminosäure-herbiziden
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
HK1001719A1 (en) Muscle relaxant pharmaceutical compositions
HUP9900085A3 (en) Azine derivatives, of amino acids and pharmaceutical compositions containing them
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
YU20050685A (sh) Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
CA2218643A1 (fr) Composition pharmaceutique orale de composes de piperidinoalcanol sous forme de solutions
ATE219763T1 (de) Amid enthaltende kosmetische zusammensetzungen und neue amide
AU3494093A (en) S-lipophilic aliphatic carbonyl {n-mercaptoacyl-(amino acid or peptide)} compounds as antihypertensive agents

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131002